USFDA Approved Latest Drug for Lung Cancer Patients
Beacon Pharmaceuticals Limited, the leading oncology company in Bangladesh, has introduced a groundbreaking treatment for lung cancer: Tagrix, the first global generic version of osimertinib.
Beacon Pharmaceuticals has become a beacon of wellness across Bangladesh. Our impactful contributions in oncology, hepatitis, rheumatic arthritis, and diabetic products have significantly enriched the lives of the nation's people. As a leading player in these critical healthcare sectors, Beacon Pharmaceuticals continues to play a pivotal role in enhancing healthcare standards, ensuring access to quality treatments, and ultimately improving the well-being of the community across Bangladesh.
Global Business Operation Team
Monjurul Alam
CEO, Global Business
Arifa Khan Mouree
Deputy Manager, Global Business
Md. Abdullah Al Mamun
Assistant Manager, Global Business
Md. Shamiul Islam
Assistant Manager, Global Business
Md. Sayeed Ahmed
Assistant Manager, Global Business
BEACON'S GLOBAL NETWORK
ASEAN & SAARC Region
Arifa Khan Mouree
Nepal, Vietnam, Cambodia, Sri Lanka, Maldives, HongKong, Philippines, Myanmar, Thailand
+8801730026183
mouree@beaconmedicare.com.bd
AFRICA
Md. Abdullah Al Mamun
East Africa: Ethiopia, Somalia, Uganda, Sudan, Mauritius West Africa: Ghana, Nigeria Southern Africa: Zimbabwe, Zambia, Botswana, Namibia, Lesotho Central Africa: Tchad, Cameroon
+8801708805822
mamun@beaconmedicare.com.bd
LATAM & West Asia
Md. Shamiul Islam
Ecuador, Costa Rica, Venezuela, Mexico, Brazil, Guatemala, Panama, El Salvador, Guyana, Peru. West Asia: Syria, Iraq, Jordan, Yemen, Lebanon, Kuwait, Cyprus
+8801708805837
shamiul@beaconmedicare.com.bd
CIS & EU
Md. Sayeed Ahmed
Uzbekistan, Kazakhstan, Kyrgyzstan, Tajikistan, Azerbaijan EU: Georgia, Belarus, San marino, Kosovo